Promotion Manuscript of Hubei Muya Biotechnology

Ginkgo, also known as Gongsun Tree, first appeared in the carboniferous period 345 million years ago. It is a relic plant from the Ancient Permian period. It is calledregarded as "living fossil". Ginkgo tree is full of treasure, and it is believed in the traditional Chinese medicine theory believes that ginkgo leaves can boost blood circulation and remove blood stasis, clear collaterals and kill pain, astringe lung and relieve asthma, resolve turbidity and lower blood lipid, which can be applied to treat thoracic obstruction, cardialgia, stroke, hemiplegiaand aphasia  caused by stasis blocking channels. Modern scientific researches have found that ginkgo biloba leaves contain more than 160 kinds of effective medicinal ingredients. Among them, there are 35 kinds of flavonoids and lactones. It also contains terpenoids, phenols, amino acids and various trace elements. Flavonoids and ginkgolides, the most representative flavonoids in ginkgo biloba leaves, inhibit platelet aggregation and scavenge free radicals in human body. It is widely used in medicine, dietary supplement, food additives, energy drinks and cosmetics. As the aging in China becomes more serious and the demand for cardiovascular dietary supplements is increasing, the deep processing industry of ginkgo biloba showshas a huge development prospect.

Hubei Muya Biotechnology Co., Ltd is a large modern pharmaceutical enterprise specializing in ginkgo biloba cultivation and deep processing. In 2014, it was registered in Dawu County Yangping Industrial Park with total assets of 280 million yuan. The factory covers an area of 100.4 mu with an additional ginkgo cultivation base of 10,500 mu. Currently, there are 105 employees, and among which more than 30% of themwhom are technological talents engaging in the research and development (R&D) of high-tech products.

Muya always adheres to the development concept of "relying on resources and, science and technology, strictly ensuring quality, and serving health". The company implements the one-stop development mode of R&D, production and sales of medicinal materials cultivation--extraction--development of drugs and dietary supplements. The company, with strong research and development strength, and the enterprising spirit of continuous innovation, is committed to developing natural biological health industry. At present, the company has obtained Drug Production License and the production record for ginkgo biloba extraction has been completed. The record number is ZTCB20180090 e.

The planting base of the company is located in Dawu, Hubei Province, at the border of Hubei provinceProvince and Henan provinceProvince, southwest of Dabie mountain vein. There are abundant rain, plenty of rivers with a good ecological environment. Ginkgo biloba planting base owns transfer lands of more than 10,000 mu, which are all independently managed by the company. At present, the entire ginkgo base has constructed and hardened roads for about 110 kilometers. It has drilled 30 deep wells and built 110 reservoirs with varied sizes. Three living areas and one drying workshop equipped with one ginkgo leaf drying production line have been built in the base. Its annual production and processing capacity is 5,000 tons. By 2017, ginkgo trees of more than 10,500 mu have been planted and the total number of ginkgo trees has reached more than 18 million. In 2017, it was rated as a key leading enterprise in Hubei provinceProvince. Ginkgo base of the company developeddevelops rapidly and is managed well. With the coming of productive period, the yield of dry leaf will increase substantially year by year. The company fully implements the concept of green agriculture and green herbs. It aims at building a green traditional Chinese medicine base with no pesticide risks in plants, water sources and soil. Besides, the company cooperates with scientific institutes to carry out biocontrol studies, which improves the level of cultivation management. In addition, the company also adopts pollution-free pesticide technology measures to comprehensively control pests and diseases. At the same time, by taking the advantage in proprietary trading,the company implements GAP in the whole process of planting, picking, processing and storing products to ensure that the amounts of pesticide residues are lower than FAO/WHO or national standards.

Ginkgo biloba deep processing plant covers a total area of 100.4 mu and is designed and constructed in accordance with GMP requirements. At the same time, the company invests heavily in the construction of GMP ginkgo biloba leaf extraction workshop and technology research and development center with leading levels in China. The company is equipped with crushers, outfeed conveyors, feeding conveyors, dynamic extracting tanks, continuous countercurrent extraction machine sets, extracting tank deslagging and slag-extruding system, macropor